Английская Википедия:Aprocitentan

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

Aprocitentan is an endothelin receptor antagonist active at both endothelin A and endothelin B receptors.[1] It is developed for resistant hypertension by Idorsia, which sold it to Janssen but purchased the rights back in 2023 for $343 million.[2]

Aprocitentan is an active metabolite of macitentan.[3]

References

Шаблон:Reflist

Шаблон:Cardiovascular-system-drug-stub